pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

32,043 catalysts · 12,540 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 0 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 14 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 11 catalysts2026-10-29: 20 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2013-04-26×clear all
type
  • approval12,540
  • device 510k5,000
  • grant4,728
  • 8k filing2,984
  • device pma2,000
  • device recall2,000
  • recall1,126
  • device adverse event1,000
  • earnings572
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 3, 2014

    6
    ›Feb 5, 2014approval4568d agoPYLERA (BISMUTH SUBCITRATE POTASSIUM) — FDA approval

    Sponsor: LABS JUVISE. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 7, 2014approval4566d agoOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›Feb 7, 2014approval4566d agoAMMONIA N 13 (AMMONIA N-13) — FDA approval

    Sponsor: WA UNIV SCH MED. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 7, 2014approval4566d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Feb 7, 2014approval4566d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: AUROBINDO PHARMA USA. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Feb 9, 2014approval4564d agoVIVITROL (NALTREXONE) — FDA approvalnaltrexone ER

    Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →naltrexone ER →fda approvals ↗

    Week of Feb 10, 2014

    6
    ›Feb 12, 2014approval4561d agoTEMOZOLOMIDE — FDA approvalAreva Pharmaceuticals Inc

    Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 12, 2014approval

    Week of Feb 17, 2014

    9
    ›Feb 18, 2014approval4555d agoJUXTAPID (LOMITAPIDE MESYLATE) — FDA approvalChiesi USA Inc

    Sponsor: CHIESI. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 18, 2014approval

    Week of Feb 24, 2014

    6
    ›Feb 26, 2014approval4547d agoZIRGAN (GANCICLOVIR) — FDA approvalganciclovir

    Sponsor: BAUSCH AND LOMB. Form: GEL. Route: OPHTHALMIC

    full page →ganciclovir →fda approvals ↗
    ›Feb 26, 2014approval

    Week of Mar 3, 2014

    4
    ›Mar 4, 2014approval4541d agoSTELARA (USTEKINUMAB) — FDA approvalJOHNSON & JOHNSON

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 6, 2014approval

    Week of Mar 10, 2014

    7
    ›Mar 11, 2014approval4534d agoPROSCAR (FINASTERIDE) — FDA approvalPROSCAR

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →PROSCAR →fda approvals ↗
    ›Mar 11, 2014approval

    Week of Mar 17, 2014

    11
    ›Mar 18, 2014approval4527d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →GLYCOPYRROLATE →fda approvals ↗
    ›Mar 20, 2014approval

    Week of Mar 24, 2014

    1
    ›Mar 24, 2014approval4521d agoADRENACLICK (EPINEPHRINE) — FDA approvalViatris Inc

    Sponsor: IMPAX. Form: INJECTABLE. Route: INTRAMUSCULAR, SUBCUTANEOUS

    full page →fda approvals ↗
    ← prev
    page 9 of 641
    next →
    4561d ago
    IMBRUVICA (IBRUTINIB) — FDA approvalAbbVie Inc.

    Sponsor: PHARMACYCLICS LLC. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 13, 2014approval4560d agoXARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 14, 2014approval4559d agoSTALEVO 75 (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL

    full page →carbidopa →fda approvals ↗
    ›Feb 14, 2014approval4559d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 14, 2014approval4559d agoVIMIZIM (ELOSULFASE ALFA) — FDA approvalBIOMARIN PHARMACEUTICAL INC

    Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    4555d ago
    ZYPREXA RELPREVV (OLANZAPINE PAMOATE) — FDA approvalCHEPLAPHARM Arzneimittel GmbH

    Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Feb 19, 2014approval4554d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Feb 19, 2014approval4554d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Feb 19, 2014approval4554d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Feb 19, 2014approval4554d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

    Sponsor: TORRENT PHARMS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Feb 19, 2014approval4554d agoPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE (CODEINE PHOSPHATE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE

    Sponsor: ACTAVIS MID ATLANTIC. Form: SYRUP. Route: ORAL

    full page →PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE →fda approvals ↗
    ›Feb 21, 2014approval4552d agoKALYDECO (IVACAFTOR) — FDA approvalVertex, Inc.

    Sponsor: VERTEX PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 21, 2014approval4552d agoXELJANZ (TOFACITINIB CITRATE) — FDA approvalBiocon Pharma Ltd

    Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    4547d ago
    HUMIRA (ADALIMUMAB) — FDA approvaladalimumab

    Sponsor: ABBVIE INC. Form: VIAL

    full page →adalimumab →fda approvals ↗
    ›Feb 27, 2014approval4546d agoCEREZYME (IMIGLUCERASE) — FDA approvalimiglucerase

    Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION

    full page →imiglucerase →fda approvals ↗
    ›Feb 28, 2014approval4545d agoMEN'S ROGAINE (MINOXIDIL) — FDA approvalVeradermics, Inc

    Sponsor: KENVUE BRANDS. Form: AEROSOL, FOAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 28, 2014approval4545d agoCOMETRIQ (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

    Sponsor: EXELIXIS. Form: CAPSULE. Route: ORAL

    full page →cabozantinib s-malate →fda approvals ↗
    ›Feb 28, 2014approval4545d agoTRILEPTAL (OXCARBAZEPINE) — FDA approvalOXCARBAZEPINE

    Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL

    full page →OXCARBAZEPINE →fda approvals ↗
    4539d ago
    XARELTO (RIVAROXABAN) — FDA approvalJanssen Therapeutics

    Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 6, 2014approval4539d agoALDACTAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Mar 7, 2014approval4538d agoSTAVZOR (VALPROIC ACID) — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    4534d ago
    QUDEXY XR (TOPIRAMATE) — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2014approval4534d agoAKTEN (LIDOCAINE HYDROCHLORIDE) — FDA approvalLaryng-O-Jet

    Sponsor: THEA PHARMA. Form: GEL. Route: OPHTHALMIC

    full page →Laryng-O-Jet →fda approvals ↗
    ›Mar 12, 2014approval4533d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: MOUNTAIN. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 12, 2014approval4533d agoSUBOXONE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 13, 2014approval4532d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

    Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

    full page →POSACONAZOLE →fda approvals ↗
    ›Mar 14, 2014approval4531d agoTRELSTAR (TRIPTORELIN PAMOATE) — FDA approvaltriptorelin pamoate ER

    Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR

    full page →triptorelin pamoate ER →fda approvals ↗
    4525d ago
    ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalEon Labs Inc

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 20, 2014approval4525d agoFENTANYL CITRATE — FDA approvalEffentora

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →Effentora →fda approvals ↗
    ›Mar 20, 2014approval4525d agoSUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approvalsufentanil citrate

    Sponsor: RISING. Form: INJECTABLE. Route: INJECTION

    full page →sufentanil citrate →fda approvals ↗
    ›Mar 20, 2014approval4525d agoACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalEon Labs Inc

    Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 20, 2014approval4525d agoACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN) — FDA approvalEon Labs Inc

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 20, 2014approval4525d agoPEPCID COMPLETE (CALCIUM CARBONATE) — FDA approvalKenvue Inc.

    Sponsor: KENVUE BRANDS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 20, 2014approval4525d agoBREVIBLOC (ESMOLOL HYDROCHLORIDE) — FDA approvalESMOLOL HYDROCHLORIDE

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →ESMOLOL HYDROCHLORIDE →fda approvals ↗
    ›Mar 20, 2014approval4525d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

    Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 20, 2014approval4525d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

    Sponsor: SUN PHARM INDS. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 21, 2014approval4524d agoOTEZLA (APREMILAST) — FDA approvalapremilast

    Sponsor: AMGEN INC. Form: TABLET. Route: ORAL

    full page →apremilast →fda approvals ↗
    $ALKS49.17+1.65%
    $JNJ259.24+0.88%
    $VTRS16.43+0.86%
    $BLCO16.78+2.63%
    $OGN13.60+0.37%
    $ABBV246.04+0.89%
    $BMRN63.81+3.82%
    $VERX11.94+3.20%
    $RDY12.22+0.91%
    $ORN12.42-2.13%
    $ABBV246.04+0.89%
    $PFE26.76+2.14%
    $COLL29.47+1.24%
    $ABBV246.04+0.89%
    $MANE114.39+5.28%
    $EXEL54.07+3.58%
    $NVS156.33+1.37%
    $INDV38.82+0.39%
    $KVUE19.23+0.26%
    $AMGN410.94+1.51%